1. Volume 68, Issue 3, Pages 1206-1214 (September 2005)
Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry 
Gabriele Lehmann, Günter Stein, Manfred Hller, Rudolf Schemer, Kastooriranganathan Ramakrishnan, William G. Goodman 
Kidney International 
Volume 68, Issue 3, Pages (September 2005)
DOI: /j x
Copyright © 2005 International Society of Nephrology Terms and Conditions

2. Figure 1
Values for Bio-Intact parathyroid hormone (BI-PTH) (left) and intact parathyroid hormone (I-PTH) (right) in patients with either high bone turnover (HTO) or low bone turnover (LTO) skeletal lesions of renal osteodystrophy. Results for patients with chronic kidney disease (CKD) stages 3/4 (upper panels) and in those with CKD stage 5 (lower panels) are presented separately. Dashed lines depict the range for I-PTH recommended by the K/DOQI guidelines of the National Kidney Foundation for patients with CKD stage 5.
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

3. Figure 2
Linear regression (Passing and Bablok) of Bio-Intact parathyroid hormone (BI-PTH) and intact parathyroid hormone (I-PTH) of (A) all patients (N = 130), (B) nondialysis patients (N = 35) (notice the different scale), and (C) dialysis patients (N = 95).
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions

4. Figure 3
Receiver operating characteristic (ROC) curves for the prediction of bone turnover (low bone turnover vs. high bone turnover) in predialysis [chronic kidney disease (CKD) stages 3/4] (N = 26) and chronically dialyzed (CKD stage 5) (N = 78) patients by Bio-Intact parathyroid hormone (BI-PTH), intact parathyroid hormone (I-PTH), and the ratio BI-PTH/(I-PTH - BI-PTH).
Kidney International  , DOI: ( /j x)
Copyright © 2005 International Society of Nephrology Terms and Conditions